In the realm of low-volume life science logistics, Andy Clarke, Country Manager at life science logistics provider YSDS, examines the challenges encountered by companies and their logistics partners. Despite growth in the low-volume market, shipping high-value and time-sensitive items pose significant hurdles, necessitating effective communication and a cohesive blend of human interaction and technological advancements.
In an article with European Pharmaceutical Manufacturer, Andy shared the complexities and challenges of shipping low-volume, high-value life science products, emphasising the importance of specialised logistics partners and effective communication between shippers and providers. It highlights the critical role these shipments play in the success of companies, particularly start-ups and SMEs, and underscores the need for tailored solutions due to the unique nature of the items involved.
Additionally, it touches on the growth potential of this market segment and the necessity for logistics companies to prioritise understanding their clients' needs over automation. Reflecting on the future landscape of logistics, and the accelerated digitalisation driven by the COVID-19 pandemic. Bionow members can benefit from insights into navigating the intricacies of shipping in the life sciences sector and the value of strategic partnerships in ensuring the successful delivery of critical shipments.